UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 822

Sortiert nach

Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction

The Journal of experimental medicine, 2009-01, Vol.206 (1), p.113-123

2009

Link zum Volltext

Verfügbarkeit prüfen

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

The New England journal of medicine, 2013-04, Vol.368 (15), p.1379-1387

2013

Link zum Volltext

Verfügbarkeit prüfen

Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality

International journal of cardiology, 2017-10, Vol.245, p.27-34

2017

Link zum Volltext

Verfügbarkeit prüfen

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

The Lancet (British edition), 2008-04, Vol.371 (9621), p.1353-1363

2008

Link zum Volltext

Verfügbarkeit prüfen

Thrombolysis for acute myocardial infarction

Circulation (New York, N.Y.), 1998-04, Vol.97 (16), p.1632-1646

1998

Link zum Volltext

Verfügbarkeit prüfen

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial

The Lancet (British edition), 2012-10, Vol.380 (9850), p.1317-1324

2012

Link zum Volltext

Verfügbarkeit prüfen

Evolving Therapies for Myocardial Ischemia/Reperfusion Injury

Journal of the American College of Cardiology, 2015-04, Vol.65 (14), p.1454-1471

2015

Link zum Volltext

Verfügbarkeit prüfen

Patients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment Changes

Journal of the American College of Cardiology, 2005-07, Vol.46 (1), p.29-38

2005

Link zum Volltext

Verfügbarkeit prüfen

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study

European heart journal. Acute cardiovascular care, 2015-12, Vol.4 (6), p.509-517

2015

Link zum Volltext

Verfügbarkeit prüfen

IMPACT OF A SWITCH FROM DUAL ANTIPLATELET THERAPY TO SINGLE ANTIPLATELET THERAPY IN DIABETES AND NON-DIABETES POST ACS: INSIGHTS FROM THE EPICOR AND EPICOR-ASIA STUDIES

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.110-110

2017

Link zum Volltext

Verfügbarkeit prüfen

ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction : Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

Circulation (New York, N.Y.), 2008-09, Vol.118 (13), p.1335-1346

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Thrombolysis Versus Surgery as a First Line Therapy for Prosthetic Heart Valve Thrombosis

The American journal of cardiology, 2011-01, Vol.107 (2), p.275-279

2011

Link zum Volltext

Verfügbarkeit prüfen

Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography

The American heart journal, 2009-04, Vol.157 (4), p.716-723

2009

Link zum Volltext

Verfügbarkeit prüfen

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

The New England journal of medicine, 2013-09, Vol.369 (13), p.1206-1214

2013

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular disease on a global scale: defining the path forward for research and practice

European heart journal, 2007-11, Vol.28 (21), p.2678-2684

2007

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

Critical care medicine, 2011-01, Vol.39 (1), p.78-83

2011

Link zum Volltext

Verfügbarkeit prüfen

The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study

The American heart journal, 2010-07, Vol.160 (1), p.30-35.e1

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial

Journal of the American Heart Association, 2021-09, Vol.10 (17), p.e020446-e020446

2021

Link zum Volltext

Verfügbarkeit prüfen

International Variation in the Use of Blood Transfusion in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

The American journal of cardiology, 2008, Vol.101 (1), p.25-29.e2

2008

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

Journal of the American College of Cardiology, 2013-07, Vol.62 (3), p.242-251

2013

Link zum Volltext

Verfügbarkeit prüfen

Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?

The New England journal of medicine, 2018-11, Vol.379 (18), p.1775-1776

2018

Link zum Volltext

Verfügbarkeit prüfen

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

European heart journal, 2017-03, Vol.38 (11), p.804-810

2017

Link zum Volltext

Verfügbarkeit prüfen

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

PLoS medicine, 2007-02, Vol.4 (2), p.e12-e12

2007

Link zum Volltext

Verfügbarkeit prüfen

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial

The American heart journal, 2011-05, Vol.161 (5), p.848-854

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 822

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(795)
Mit Volltextzugriff
(767)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(553)
Life Sciences & Biomedicine
(547)
Humans
(481)
Cardiovascular System & Cardiology
(440)
Cardiac & Cardiovascular Systems
(431)
Male
(323)
Female
(319)
Biological And Medical Sciences
(310)
Medical Sciences
(306)
Middle Aged
(275)
Aged
(264)
Cardiology. Vascular System
(193)
Heart
(185)
Coronary Heart Disease
(167)
Treatment Outcome
(144)
Heart Attacks
(138)
Myocardial Infarction - Drug Therapy
(133)
Myocardial Infarction
(119)
Mortality
(106)
Cardiology
(102)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

Thrombolysis for acute myocardial infarction

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial

Evolving Therapies for Myocardial Ischemia/Reperfusion Injury

Patients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment Changes

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study

IMPACT OF A SWITCH FROM DUAL ANTIPLATELET THERAPY TO SINGLE ANTIPLATELET THERAPY IN DIABETES AND NON-DIABETES POST ACS: INSIGHTS FROM THE EPICOR AND EPICOR-ASIA STUDIES

ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction : Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

Comparison of Thrombolysis Versus Surgery as a First Line Therapy for Prosthetic Heart Valve Thrombosis

Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

Cardiovascular disease on a global scale: defining the path forward for research and practice

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study

Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial

International Variation in the Use of Blood Transfusion in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial

Suchergebnisse filtern